Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
...
Next
(4)
•••
2busy2
X
View Profile
View Bullboard History
Post by
2busy2
on Jan 16, 2024 10:27pm
$ 1.75 on the high and 4 cents on the low ,DONT
you feel terribly taking advantage of the company at these LOWS , ooooooooooooooohohohohoho
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Jan 16, 2024 9:22pm
Great LABS forum until
The trolls show up. Both of you, promote your garbage stocks somewhere else, really pathetic and sad....best group/discussion on MEDIPHARM LABS...props to stockhouse for introducing IGNORE..
(4)
•••
2busy2
X
View Profile
View Bullboard History
Post by
2busy2
on Jan 16, 2024 7:17pm
or it cud be Latta BO Shet - LABS
high of what $2 dollars - ure stealin it ooooooooooooohoohoho
(4)
•••
2busy2
X
View Profile
View Bullboard History
Post by
2busy2
on Jan 16, 2024 7:01pm
la BS
the bull chet
(4)
•••
2busy2
X
View Profile
View Bullboard History
Post by
2busy2
on Jan 16, 2024 6:53pm
well pfiser or who ever doesnt want us anymore
O well what to do - B. S.>>>>>>>>>>
(4)
•••
2busy2
X
View Profile
View Bullboard History
Post by
2busy2
on Jan 16, 2024 6:51pm
So they didnt mention a name of a Partner
and the stock went down and NOW the can mention the partner name hen they with draw support and
...more
(56)
•••
Redwine12345
X
View Profile
View Bullboard History
Comment by
Redwine12345
on Jan 16, 2024 6:25pm
RE:RE:RE:RE:RE:RE:TD Bank gives a current book value of $0.20 for LABS !! :)
Subaru, this stock was going down from Apr 2019 to April-2022. It is going sideways almost 2 years. Sure you can buy at seven cents and wait for who knows how long with hope that it will open one day
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Jan 16, 2024 5:03pm
RE:RE:RE:RE:RE:TD Bank gives a current book value of $0.20 for LABS !! :)
Redwine, you realize waiting until you see a 'breakout' might be too late for a couple of reasons. With smart phones and apps, news travels and is dissipated extremely more quickly than
...more
(56)
•••
Redwine12345
X
View Profile
View Bullboard History
Comment by
Redwine12345
on Jan 16, 2024 3:26pm
RE:RE:RE:RE:TD Bank gives a current book value of $0.20 for LABS !! :)
Maybe you should. :). Check VPH. I am not promoting it. Until I see breakout, nothing to buy, nothing to sell.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Jan 16, 2024 1:52pm
ANVISA (Brazil) for generic Epidiolex should be very close
as well. Pidduck originally mentioned in Q4, 2023 when news becomes available.
(645)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Comment by
1hot-techwoman
on Jan 16, 2024 1:40pm
RE:RE:RE:TD Bank gives a current book value of $0.20 for LABS !! :)
I Would,t think its time to be selling , lets say that !! :)
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Jan 16, 2024 10:46am
Does anyone know how old Anne Miligram, head of DEA is?
I do believe her generation was more 'open minded' to cannabis use. Where did Life π come from, within the framework of immediacy, we came from the Cradle π, the Planet π and that
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Jan 16, 2024 10:35am
RE:eh, PUMPER why dont ya tell us about the BIG Secret
I will share some Truth π with you. This Planet π may have about another 20 years give or take remaining to support Life π on it. Here's the science behind that and that is why
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Jan 16, 2024 9:12am
RE:eh, PUMPER why dont ya tell us about the BIG Secret
why dont you just go somewhere else with your drivell no one want to buy the stocks you are promoting get it?!
Prev
...
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >